A carregar...
Dasatinib enhances megakaryocyte differentiation but inhibits platelet formation
Dasatinib is a novel, potent, ATP-competitive inhibitor of Bcr-Abl, cKIT, and Src family kinases that exhibits efficacy in patients with imatinib-resistant chronic myelogenous leukemia. Dasatinib treatment is associated with mild thrombocytopenia and an increased risk of bleeding, but its biological...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3109542/ https://ncbi.nlm.nih.gov/pubmed/21385851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-12-326850 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|